22q13.3 deletion syndrome: A recognizable malformation syndrome associated with marked speech and language delay

被引:75
作者
Cusmano-Ozog, Kristina
Manning, Melanie A.
Hoyme, H. Eugene
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Clin Cytogenet Lab, Stanford, CA 94305 USA
关键词
deletion; 22q13.3; terminal 22q deletion syndrome; chromosome anomaly; dysmorphology; autism; speech and language delay; developmental disabilities;
D O I
10.1002/ajmg.c.30155
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The 22q13.3 deletion syndrome is a recognizable malformation syndrome associated with developmental delay, hypotonia, delayed or absent speech, autistic-like behavior, normal to accelerated growth and dysmorphic facies. The prevalence of this disorder is unknown, but it is likely under-diagnosed. Age at diagnosis has varied widely, from cases diagnosed prenatally to 46 years. Males and females are equally affected. The distal 22q deletion can be detected occasionally by routine or high resolution chromosome analysis; however, the majority of cases are detected by FISH analysis, associated with deletion of the ARSA (control) probe when performing a FISH analysis for the velocardiofacial syndrome (del 22q11.2). The 22q13.3 deletion syndrome can accompany a simple chromosome deletion, an unbalanced translocation, or a ring chromosome. Primary care physicians, in addition to numerous specialists, play an important role in caring for patients with this disorder. Although the dysmorphic features observed in this condition are nonspecific, it is an important consideration in the differential diagnosis of children with developmental delay, hypotonia, marked speech and language disability, autistic-like features, multiple minor anomalies, and normal growth and head circumference. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:393 / 398
页数:6
相关论文
共 39 条
[31]   Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype [J].
Prasad, C ;
Prasad, AN ;
Chodirker, BN ;
Lee, C ;
Dawson, AK ;
Jocelyn, LJ ;
Chudley, AE .
CLINICAL GENETICS, 2000, 57 (02) :103-109
[32]   PARTIAL MONOSOMY FOR CHROMOSOME 22 IN A PATIENT WITH DEL(22)(PTER-]Q13 1=Q13 33-]QTER) [J].
ROMAIN, DR ;
GOLDSMITH, J ;
CAIRNEY, H ;
COLUMBANOGREEN, LM ;
SMYTHE, RH ;
PARFITT, RG .
JOURNAL OF MEDICAL GENETICS, 1990, 27 (09) :588-589
[33]   Deletion mapping by FISH with BACs in patients with partial monosomy 22q13 [J].
Schröder, K ;
Schuffenhauer, S ;
Seidel, H ;
Bartsch, O ;
Blin, N ;
Hinkel, GK ;
Schmitt, H .
HUMAN GENETICS, 1998, 102 (05) :557-561
[34]   The phenotypic effects of chromosome rearrangement involving bands 7q21.3 and 22q13.3 [J].
Slavotinek, A ;
Maher, E ;
Gregory, P ;
Rowlandson, P ;
Huson, SM .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (10) :857-861
[35]   Two brothers with 22q13 deletion syndrome and features suggestive of the Clark-Baraitser syndrome [J].
Tabolacci, E ;
Zollino, M ;
Lecce, R ;
Sangiorgi, E ;
Gurrieri, F ;
Leuzzi, V ;
Opitz, JM ;
Neri, G .
CLINICAL DYSMORPHOLOGY, 2005, 14 (03) :127-132
[36]   A FAMILIAL PERICENTRIC-INVERSION OF CHROMOSOME-22 WITH A RECOMBINANT SUBJECT ILLUSTRATING A PURE PARTIAL MONOSOMY SYNDROME [J].
WATT, JL ;
OLSON, IA ;
JOHNSTON, AW ;
ROSS, HS ;
COUZIN, DA ;
STEPHEN, GS .
JOURNAL OF MEDICAL GENETICS, 1985, 22 (04) :283-287
[37]   Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms [J].
Wilson, HL ;
Wong, ACC ;
Shaw, SR ;
Tse, WY ;
Stapleton, GA ;
Phelan, MC ;
Hu, S ;
Marshall, J ;
McDermid, HE .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (08) :575-584
[38]  
Wong ACC, 1997, AM J HUM GENET, V60, P113
[39]  
ZWAIGENBAUM L, 1990, AM J HUM GENET, V47, pA45